High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma

SIMPLE SUMMARY: Real-time ex vivo drug testing tailors individual therapeutics based on predicted drug responses. Most technologies to date rely on conventional drug screening that provides low confidence data. Here, we present high-content analysis-based drug testing of glioblastoma patients to ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jeong-Woo, Oh, Yun Jeong, Han, Suji, Her, Nam-Gu, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864197/
https://www.ncbi.nlm.nih.gov/pubmed/33498427
http://dx.doi.org/10.3390/cancers13030372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864197/
https://www.ncbi.nlm.nih.gov/pubmed/33498427
http://dx.doi.org/10.3390/cancers13030372

Ejemplares similares